

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.55998544 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.34483492 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.34483492 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.34483492 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.34483492 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.34483492 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.34483492 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.20919671 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.06414728 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56059552 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.56059552 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.54209171 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.36659262 |
| 14 | response to peptidoglycan (GO:0032494) | 4.30130608 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.17294548 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.16937816 |
| 17 | leukocyte aggregation (GO:0070486) | 4.11268552 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.07922551 |
| 19 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.04650186 |
| 20 | respiratory burst (GO:0045730) | 4.03394738 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.90308309 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.90308309 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 3.88886347 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.88014942 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.76543997 |
| 26 | detection of other organism (GO:0098543) | 3.74648256 |
| 27 | T cell migration (GO:0072678) | 3.73090222 |
| 28 | interferon-gamma production (GO:0032609) | 3.72459235 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 3.69654796 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.67538235 |
| 31 | response to host immune response (GO:0052572) | 3.67538235 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.67395877 |
| 33 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.66983440 |
| 34 | detection of bacterium (GO:0016045) | 3.65560507 |
| 35 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55014969 |
| 36 | cellular extravasation (GO:0045123) | 3.54486977 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.54334843 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.51051664 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.47304201 |
| 40 | neutrophil activation (GO:0042119) | 3.45667997 |
| 41 | mast cell activation (GO:0045576) | 3.44247052 |
| 42 | regulation of antigen processing and presentation (GO:0002577) | 3.41731993 |
| 43 | negative T cell selection (GO:0043383) | 3.41661041 |
| 44 | granulocyte activation (GO:0036230) | 3.41005981 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.40039237 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.36779590 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31873032 |
| 48 | response to host defenses (GO:0052200) | 3.30799432 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30799432 |
| 50 | response to host (GO:0075136) | 3.30799432 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30391217 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28866372 |
| 53 | microglial cell activation (GO:0001774) | 3.28449479 |
| 54 | defense response to protozoan (GO:0042832) | 3.28113488 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25155861 |
| 56 | regulation of mast cell activation (GO:0033003) | 3.25125547 |
| 57 | mature B cell differentiation (GO:0002335) | 3.25070585 |
| 58 | B cell mediated immunity (GO:0019724) | 3.24268438 |
| 59 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.24085618 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 3.22865071 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.22762127 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22288405 |
| 63 | myeloid dendritic cell activation (GO:0001773) | 3.21890209 |
| 64 | detection of external biotic stimulus (GO:0098581) | 3.21787002 |
| 65 | tolerance induction (GO:0002507) | 3.19962140 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.19682607 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.19682607 |
| 68 | response to type I interferon (GO:0034340) | 3.18065772 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17864223 |
| 70 | positive regulation of mast cell activation (GO:0033005) | 3.17375006 |
| 71 | negative regulation of mast cell activation (GO:0033004) | 3.14407706 |
| 72 | amino sugar catabolic process (GO:0046348) | 3.13562100 |
| 73 | pinocytosis (GO:0006907) | 3.10700070 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.08093285 |
| 75 | positive thymic T cell selection (GO:0045059) | 3.06938313 |
| 76 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.06587772 |
| 77 | response to protozoan (GO:0001562) | 3.06572928 |
| 78 | regulation of mast cell degranulation (GO:0043304) | 3.05745717 |
| 79 | T-helper 1 type immune response (GO:0042088) | 3.03532582 |
| 80 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00806106 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.00739065 |
| 82 | regulation of leukocyte degranulation (GO:0043300) | 3.00128153 |
| 83 | myeloid dendritic cell differentiation (GO:0043011) | 2.98634914 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 2.97306595 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96790426 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 2.96254098 |
| 87 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95880400 |
| 88 | superoxide anion generation (GO:0042554) | 2.94349773 |
| 89 | response to interleukin-15 (GO:0070672) | 2.92275668 |
| 90 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91738523 |
| 91 | positive regulation of interferon-beta production (GO:0032728) | 2.91478734 |
| 92 | germinal center formation (GO:0002467) | 2.90670825 |
| 93 | actin nucleation (GO:0045010) | 2.90435372 |
| 94 | leukocyte cell-cell adhesion (GO:0007159) | 2.89885904 |
| 95 | cellular response to interferon-beta (GO:0035458) | 2.89746743 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.89088338 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.88247284 |
| 98 | positive regulation of macrophage differentiation (GO:0045651) | 2.87920987 |
| 99 | oligosaccharide catabolic process (GO:0009313) | 2.87713054 |
| 100 | glycolipid catabolic process (GO:0019377) | 2.87502610 |
| 101 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.87255412 |
| 102 | negative regulation of phagocytosis (GO:0050765) | 2.86659216 |
| 103 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86561749 |
| 104 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86356070 |
| 105 | leukocyte degranulation (GO:0043299) | 2.86203682 |
| 106 | NIK/NF-kappaB signaling (GO:0038061) | 2.85318131 |
| 107 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83852989 |
| 108 | myeloid leukocyte activation (GO:0002274) | 2.83741101 |
| 109 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82521687 |
| 110 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.81348454 |
| 111 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81094565 |
| 112 | cellular response to zinc ion (GO:0071294) | 2.81035555 |
| 113 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.80817572 |
| 114 | natural killer cell mediated immunity (GO:0002228) | 2.80817572 |
| 115 | detection of biotic stimulus (GO:0009595) | 2.79571803 |
| 116 | negative regulation of innate immune response (GO:0045824) | 2.79428098 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78473317 |
| 118 | negative regulation of interleukin-12 production (GO:0032695) | 2.77697674 |
| 119 | mature B cell differentiation involved in immune response (GO:0002313) | 2.77532692 |
| 120 | dendritic cell differentiation (GO:0097028) | 2.77166170 |
| 121 | positive regulation of isotype switching (GO:0045830) | 2.76346810 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76163951 |
| 123 | macrophage activation (GO:0042116) | 2.74189048 |
| 124 | positive regulation of type 2 immune response (GO:0002830) | 2.74093445 |
| 125 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74004482 |
| 126 | regulation of tolerance induction (GO:0002643) | 2.73118585 |
| 127 | positive T cell selection (GO:0043368) | 2.72467719 |
| 128 | positive regulation of interferon-gamma production (GO:0032729) | 2.71791572 |
| 129 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70469269 |
| 130 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68032515 |
| 131 | T cell selection (GO:0045058) | 2.67722512 |
| 132 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.66464718 |
| 133 | positive regulation of mast cell degranulation (GO:0043306) | 2.66464718 |
| 134 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.65692676 |
| 135 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.63741538 |
| 136 | response to thyroid hormone (GO:0097066) | 2.62330742 |
| 137 | cellular response to interferon-gamma (GO:0071346) | 2.61297103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.02929219 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.02530801 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.36753236 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.66462315 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.38532626 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.23297006 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.98312208 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.83822694 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66641847 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.60270716 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.37163512 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20377032 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07632003 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05833957 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80145393 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.73432951 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.66940531 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.62241328 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54407193 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47173946 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46614213 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.43455395 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.42569007 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39803584 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31397904 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19861011 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.11408567 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10612350 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08393883 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07664234 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03750839 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99731848 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99539816 |
| 34 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98859439 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98314474 |
| 36 | * MYB_26560356_Chip-Seq_TH1_Human | 1.95747609 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.85417625 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.85169308 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83091801 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75456647 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73977530 |
| 42 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.72957106 |
| 43 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.69843994 |
| 44 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68763919 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68453206 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65332811 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62889248 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61933519 |
| 49 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54003874 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51843431 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47915448 |
| 52 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47515433 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39405463 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38396878 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.38003003 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34740015 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31272686 |
| 58 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30379940 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29551520 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27602220 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27132486 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26941145 |
| 63 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25918746 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22511703 |
| 65 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20613926 |
| 66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.18920017 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17781126 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17150871 |
| 69 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.15132392 |
| 70 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14732055 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13600703 |
| 72 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12515708 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10340556 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10326038 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09643267 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09594927 |
| 77 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09265582 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09131732 |
| 79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07179712 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03699623 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02894178 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02159117 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01331806 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00204989 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99632015 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97989511 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95649568 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95629227 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94684422 |
| 90 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93795629 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93101366 |
| 92 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91951927 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86911866 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85567131 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85347224 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85312177 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82452438 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82233943 |
| 99 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.80238662 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80206541 |
| 101 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78576925 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76875174 |
| 103 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.75459464 |
| 104 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74745491 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74542904 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71865445 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70769697 |
| 108 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.67980602 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.67078151 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67053032 |
| 111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.65746654 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.64797634 |
| 113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.63879361 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62891978 |
| 115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.62875370 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61506322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.88682620 |
| 2 | MP0005671_abnormal_response_to | 3.56596320 |
| 3 | MP0003436_decreased_susceptibility_to | 3.38507402 |
| 4 | * MP0009785_altered_susceptibility_to | 3.26559977 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.21178768 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.07446557 |
| 7 | MP0001800_abnormal_humoral_immune | 3.05014673 |
| 8 | MP0006082_CNS_inflammation | 3.04554645 |
| 9 | * MP0002419_abnormal_innate_immunity | 2.97840229 |
| 10 | MP0005387_immune_system_phenotype | 2.95991874 |
| 11 | MP0001790_abnormal_immune_system | 2.95991874 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.93513123 |
| 13 | * MP0005025_abnormal_response_to | 2.86218742 |
| 14 | MP0002723_abnormal_immune_serum | 2.79685499 |
| 15 | MP0003303_peritoneal_inflammation | 2.72642233 |
| 16 | * MP0001819_abnormal_immune_cell | 2.70671721 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.69531786 |
| 18 | MP0000685_abnormal_immune_system | 2.68039543 |
| 19 | MP0004510_myositis | 2.45633693 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.43218074 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.37369810 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.34774258 |
| 23 | MP0003724_increased_susceptibility_to | 2.27891746 |
| 24 | MP0002398_abnormal_bone_marrow | 2.23655608 |
| 25 | MP0002405_respiratory_system_inflammati | 2.22072368 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.20674563 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.17111385 |
| 28 | MP0000716_abnormal_immune_system | 2.11684597 |
| 29 | MP0005174_abnormal_tail_pigmentation | 2.03918222 |
| 30 | MP0005451_abnormal_body_composition | 1.96044616 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.86723044 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.83111062 |
| 33 | MP0002722_abnormal_immune_system | 1.76637488 |
| 34 | MP0002429_abnormal_blood_cell | 1.74683451 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.74535223 |
| 36 | MP0001853_heart_inflammation | 1.72419578 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.71906154 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.68807064 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.65508580 |
| 40 | MP0002006_tumorigenesis | 1.65145292 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.64739048 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.63835407 |
| 43 | MP0004947_skin_inflammation | 1.63815578 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.63062997 |
| 45 | MP0005310_abnormal_salivary_gland | 1.60324343 |
| 46 | MP0003448_altered_tumor_morphology | 1.54494951 |
| 47 | MP0000858_altered_metastatic_potential | 1.49952056 |
| 48 | MP0008469_abnormal_protein_level | 1.42758343 |
| 49 | MP0009764_decreased_sensitivity_to | 1.41491917 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.36687107 |
| 51 | MP0001873_stomach_inflammation | 1.35704981 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.35648962 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.35648962 |
| 54 | MP0009278_abnormal_bone_marrow | 1.31905550 |
| 55 | MP0000343_altered_response_to | 1.31409291 |
| 56 | MP0002933_joint_inflammation | 1.27767544 |
| 57 | MP0003866_abnormal_defecation | 1.25949528 |
| 58 | MP0000490_abnormal_crypts_of | 1.25050454 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.24497722 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.22629948 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.20737991 |
| 62 | MP0003279_aneurysm | 1.20372399 |
| 63 | MP0008260_abnormal_autophagy | 1.18417073 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.15628775 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.15013664 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.07701625 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.06443631 |
| 68 | MP0010307_abnormal_tumor_latency | 1.02454971 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.02311772 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.01339772 |
| 71 | MP0003329_amyloid_beta_deposits | 0.99898949 |
| 72 | MP0008004_abnormal_stomach_pH | 0.98128771 |
| 73 | MP0002095_abnormal_skin_pigmentation | 0.96925449 |
| 74 | MP0003091_abnormal_cell_migration | 0.92987318 |
| 75 | MP0000372_irregular_coat_pigmentation | 0.92158686 |
| 76 | MP0006054_spinal_hemorrhage | 0.92043965 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.91339407 |
| 78 | MP0005166_decreased_susceptibility_to | 0.89675636 |
| 79 | MP0001851_eye_inflammation | 0.89623374 |
| 80 | MP0000371_diluted_coat_color | 0.86650219 |
| 81 | MP0003075_altered_response_to | 0.86159675 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.83385969 |
| 83 | MP0002132_abnormal_respiratory_system | 0.80801239 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 0.80667281 |
| 85 | MP0001958_emphysema | 0.79784609 |
| 86 | MP0000920_abnormal_myelination | 0.77098899 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.75889437 |
| 88 | MP0005390_skeleton_phenotype | 0.75442390 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.74062411 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.73308580 |
| 91 | MP0003828_pulmonary_edema | 0.71480461 |
| 92 | MP0005165_increased_susceptibility_to | 0.70870646 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.70844313 |
| 94 | MP0004381_abnormal_hair_follicle | 0.67881377 |
| 95 | MP0001663_abnormal_digestive_system | 0.67021555 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.66888684 |
| 97 | MP0001542_abnormal_bone_strength | 0.66068437 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.66000776 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.65863176 |
| 100 | MP0009763_increased_sensitivity_to | 0.65303330 |
| 101 | MP0000604_amyloidosis | 0.60748834 |
| 102 | MP0008874_decreased_physiological_sensi | 0.59919499 |
| 103 | MP0000249_abnormal_blood_vessel | 0.59452947 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.58342474 |
| 105 | MP0003795_abnormal_bone_structure | 0.57927606 |
| 106 | MP0005023_abnormal_wound_healing | 0.57841322 |
| 107 | MP0002735_abnormal_chemical_nociception | 0.57479705 |
| 108 | MP0003693_abnormal_embryo_hatching | 0.53670871 |
| 109 | MP0003045_fibrosis | 0.48939222 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.46832862 |
| 111 | MP0005164_abnormal_response_to | 0.46011985 |
| 112 | MP0009840_abnormal_foam_cell | 0.45913027 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.45023368 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.44662728 |
| 115 | MP0008007_abnormal_cellular_replicative | 0.44229021 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.40996127 |
| 117 | MP0004883_abnormal_blood_vessel | 0.40450581 |
| 118 | MP0000313_abnormal_cell_death | 0.40378363 |
| 119 | MP0003690_abnormal_glial_cell | 0.40325526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.49090929 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.89024470 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.51019200 |
| 4 | Myositis (HP:0100614) | 4.63685247 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.39023266 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.37629567 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.32817029 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24997667 |
| 9 | Obstructive lung disease (HP:0006536) | 4.20457574 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.20457574 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.05395871 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.99951134 |
| 13 | Optic neuritis (HP:0100653) | 3.96738903 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.96738903 |
| 15 | Stomatitis (HP:0010280) | 3.89832059 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.89437573 |
| 17 | Orchitis (HP:0100796) | 3.86655742 |
| 18 | Recurrent skin infections (HP:0001581) | 3.81591023 |
| 19 | Recurrent viral infections (HP:0004429) | 3.77899851 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74388140 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74388140 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.66733700 |
| 23 | Meningitis (HP:0001287) | 3.65291678 |
| 24 | IgM deficiency (HP:0002850) | 3.57844682 |
| 25 | Vasculitis (HP:0002633) | 3.51896417 |
| 26 | Chronic otitis media (HP:0000389) | 3.48984779 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.45934502 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.39791547 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.39791547 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.39791547 |
| 31 | Gingivitis (HP:0000230) | 3.33569699 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.24794022 |
| 33 | Cellulitis (HP:0100658) | 3.16689042 |
| 34 | Abnormality of T cell number (HP:0011839) | 3.03835239 |
| 35 | T lymphocytopenia (HP:0005403) | 3.01827331 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01717703 |
| 37 | Increased IgM level (HP:0003496) | 2.99492417 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.92278918 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.89118029 |
| 40 | Petechiae (HP:0000967) | 2.88325114 |
| 41 | Abnormality of T cells (HP:0002843) | 2.81265669 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.81060869 |
| 43 | Leukocytosis (HP:0001974) | 2.75216597 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.73364065 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.73013421 |
| 46 | Purpura (HP:0000979) | 2.72586419 |
| 47 | Hemoptysis (HP:0002105) | 2.70893354 |
| 48 | Eosinophilia (HP:0001880) | 2.70830075 |
| 49 | Thyroiditis (HP:0100646) | 2.69089371 |
| 50 | Pustule (HP:0200039) | 2.66038418 |
| 51 | Osteomyelitis (HP:0002754) | 2.61570984 |
| 52 | Recurrent pneumonia (HP:0006532) | 2.58863178 |
| 53 | Nasal polyposis (HP:0100582) | 2.58262911 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.58149281 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57014529 |
| 56 | Inflammation of the large intestine (HP:0002037) | 2.55462813 |
| 57 | Increased serum ferritin (HP:0003281) | 2.52731111 |
| 58 | Prostate neoplasm (HP:0100787) | 2.52680840 |
| 59 | IgG deficiency (HP:0004315) | 2.50467826 |
| 60 | Lymphopenia (HP:0001888) | 2.48869322 |
| 61 | Granulocytopenia (HP:0001913) | 2.48761012 |
| 62 | Periodontitis (HP:0000704) | 2.48137700 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.47226700 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.45495995 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.42571233 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42053692 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.42049730 |
| 68 | Myocardial infarction (HP:0001658) | 2.40536295 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.40461143 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.40368030 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.39285478 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.38946477 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.38133065 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.37362352 |
| 75 | Encephalitis (HP:0002383) | 2.37241456 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.37223045 |
| 77 | Disinhibition (HP:0000734) | 2.35289505 |
| 78 | Arterial thrombosis (HP:0004420) | 2.34309043 |
| 79 | Chronic sinusitis (HP:0011109) | 2.33053726 |
| 80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31999551 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.31381394 |
| 82 | Combined immunodeficiency (HP:0005387) | 2.29563324 |
| 83 | Colitis (HP:0002583) | 2.28146454 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.24805770 |
| 85 | Abnormality of the nasal mucosa (HP:0000433) | 2.22595213 |
| 86 | Urticaria (HP:0001025) | 2.21786044 |
| 87 | B lymphocytopenia (HP:0010976) | 2.21524730 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.21524730 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.18800538 |
| 90 | Cheilitis (HP:0100825) | 2.18633823 |
| 91 | Upper motor neuron abnormality (HP:0002127) | 2.18491927 |
| 92 | Agnosia (HP:0010524) | 2.17858619 |
| 93 | Increased IgE level (HP:0003212) | 2.17516040 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.15205758 |
| 95 | Restrictive lung disease (HP:0002091) | 2.14987148 |
| 96 | Mucopolysacchariduria (HP:0008155) | 2.13489875 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13489875 |
| 98 | Chest pain (HP:0100749) | 2.12537656 |
| 99 | Hematochezia (HP:0002573) | 2.12476910 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.12093756 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11943101 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11943101 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11943101 |
| 104 | Thoracic kyphosis (HP:0002942) | 2.11247780 |
| 105 | Hypertensive crisis (HP:0100735) | 2.11112346 |
| 106 | Recurrent sinusitis (HP:0011108) | 2.10472325 |
| 107 | Lymphoma (HP:0002665) | 2.10094465 |
| 108 | Epistaxis (HP:0000421) | 2.09552124 |
| 109 | Chronic diarrhea (HP:0002028) | 2.09150203 |
| 110 | Gingival bleeding (HP:0000225) | 2.08614848 |
| 111 | Spondylolisthesis (HP:0003302) | 2.08612435 |
| 112 | Loss of speech (HP:0002371) | 2.06742205 |
| 113 | Albinism (HP:0001022) | 2.06706334 |
| 114 | Thrombocytosis (HP:0001894) | 2.04224241 |
| 115 | Premature loss of primary teeth (HP:0006323) | 2.03089831 |
| 116 | Axonal loss (HP:0003447) | 2.01031966 |
| 117 | Amyloidosis (HP:0011034) | 2.00469581 |
| 118 | Asymmetric septal hypertrophy (HP:0001670) | 1.91005308 |
| 119 | Vertebral compression fractures (HP:0002953) | 1.89121027 |
| 120 | Progressive neurologic deterioration (HP:0002344) | 1.87291009 |
| 121 | Pulmonary embolism (HP:0002204) | 1.86502381 |
| 122 | Polycythemia (HP:0001901) | 1.84513460 |
| 123 | Splenomegaly (HP:0001744) | 1.83066007 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82902361 |
| 125 | Mutism (HP:0002300) | 1.81216960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.99031590 |
| 2 | TXK | 4.07911365 |
| 3 | IRAK4 | 3.24575405 |
| 4 | BLK | 3.13740654 |
| 5 | MAP3K14 | 2.95759699 |
| 6 | KIT | 2.92797350 |
| 7 | TBK1 | 2.89413471 |
| 8 | IRAK3 | 2.68638775 |
| 9 | RIPK4 | 2.68521229 |
| 10 | TYK2 | 2.59778473 |
| 11 | IKBKE | 2.46038151 |
| 12 | JAK3 | 2.43458378 |
| 13 | ZAP70 | 2.30573361 |
| 14 | SYK | 2.09382347 |
| 15 | IKBKB | 1.94535958 |
| 16 | BTK | 1.94196762 |
| 17 | TEC | 1.85985848 |
| 18 | CLK1 | 1.82043867 |
| 19 | JAK1 | 1.80228956 |
| 20 | TAOK2 | 1.73851369 |
| 21 | CSF1R | 1.70407239 |
| 22 | HCK | 1.61836321 |
| 23 | MAP3K3 | 1.59101801 |
| 24 | PIM2 | 1.58352527 |
| 25 | FES | 1.57574128 |
| 26 | ITK | 1.55518582 |
| 27 | LCK | 1.52594794 |
| 28 | LYN | 1.44533385 |
| 29 | CSK | 1.44438051 |
| 30 | MAP3K12 | 1.43792385 |
| 31 | NME2 | 1.41828405 |
| 32 | STK10 | 1.32386086 |
| 33 | MAP3K13 | 1.28973058 |
| 34 | PIM1 | 1.24680114 |
| 35 | TGFBR2 | 1.23987275 |
| 36 | TAOK3 | 1.23443676 |
| 37 | GRK6 | 1.22132689 |
| 38 | SIK3 | 1.19071413 |
| 39 | CDC42BPA | 1.11674212 |
| 40 | ERN1 | 1.06372554 |
| 41 | TAOK1 | 1.05824660 |
| 42 | MAP3K1 | 1.05164978 |
| 43 | MARK3 | 1.04446229 |
| 44 | FGFR3 | 1.02847210 |
| 45 | TRIB3 | 1.01024981 |
| 46 | MOS | 0.99946519 |
| 47 | CHUK | 0.93046160 |
| 48 | DDR2 | 0.91874985 |
| 49 | FGFR4 | 0.89380086 |
| 50 | GRK7 | 0.89233740 |
| 51 | MATK | 0.88336172 |
| 52 | SIK2 | 0.83700634 |
| 53 | JAK2 | 0.82678415 |
| 54 | MAPK7 | 0.81984945 |
| 55 | TNK2 | 0.81571405 |
| 56 | NEK9 | 0.81302263 |
| 57 | PIK3CG | 0.80200341 |
| 58 | NLK | 0.79601979 |
| 59 | EPHA3 | 0.78387968 |
| 60 | YES1 | 0.77547345 |
| 61 | PDPK1 | 0.77064594 |
| 62 | SCYL2 | 0.76815445 |
| 63 | TTN | 0.74703940 |
| 64 | MAPK12 | 0.74049208 |
| 65 | ADRBK2 | 0.72180255 |
| 66 | FGR | 0.70433367 |
| 67 | TRPM7 | 0.70333353 |
| 68 | MST4 | 0.70044363 |
| 69 | EPHB1 | 0.69495330 |
| 70 | IRAK1 | 0.68112830 |
| 71 | PRKD2 | 0.64547535 |
| 72 | RPS6KA4 | 0.63343317 |
| 73 | RPS6KA6 | 0.62330379 |
| 74 | PRKCD | 0.62137631 |
| 75 | KSR2 | 0.61877060 |
| 76 | MAP2K3 | 0.61835804 |
| 77 | ICK | 0.59727329 |
| 78 | STK24 | 0.59478818 |
| 79 | CDK4 | 0.58432152 |
| 80 | STK4 | 0.57046542 |
| 81 | BMPR2 | 0.55914996 |
| 82 | PRKCQ | 0.55662193 |
| 83 | ABL1 | 0.55059375 |
| 84 | LRRK2 | 0.54791995 |
| 85 | MAP3K8 | 0.52489587 |
| 86 | KDR | 0.51997931 |
| 87 | SMG1 | 0.51762475 |
| 88 | CDK6 | 0.50757822 |
| 89 | RPS6KC1 | 0.49809248 |
| 90 | RPS6KL1 | 0.49809248 |
| 91 | MAPK11 | 0.48466308 |
| 92 | FLT3 | 0.47459407 |
| 93 | EEF2K | 0.47278036 |
| 94 | MARK2 | 0.47253588 |
| 95 | PRKCH | 0.47047249 |
| 96 | MAPKAPK2 | 0.46961897 |
| 97 | EIF2AK2 | 0.45314300 |
| 98 | CAMKK1 | 0.45152815 |
| 99 | ZAK | 0.42153194 |
| 100 | SIK1 | 0.40970989 |
| 101 | EIF2AK3 | 0.40861146 |
| 102 | MAP3K11 | 0.40326353 |
| 103 | CAMKK2 | 0.38562172 |
| 104 | HIPK2 | 0.36775281 |
| 105 | CASK | 0.36231715 |
| 106 | PAK4 | 0.35658680 |
| 107 | TESK2 | 0.35216199 |
| 108 | ABL2 | 0.34609000 |
| 109 | IRAK2 | 0.34605532 |
| 110 | FYN | 0.32865706 |
| 111 | PTK6 | 0.32792739 |
| 112 | MAPK4 | 0.32694879 |
| 113 | RPS6KA2 | 0.31963238 |
| 114 | PLK4 | 0.31424294 |
| 115 | PRKG2 | 0.31057316 |
| 116 | ARAF | 0.31018187 |
| 117 | EIF2AK1 | 0.29747252 |
| 118 | PDK1 | 0.29491215 |
| 119 | VRK1 | 0.27893631 |
| 120 | PKN2 | 0.25788553 |
| 121 | MAP2K6 | 0.25348915 |
| 122 | DAPK1 | 0.24837260 |
| 123 | TLK1 | 0.24189600 |
| 124 | EGFR | 0.24062328 |
| 125 | PRPF4B | 0.22127395 |
| 126 | TSSK6 | 0.21822334 |
| 127 | SGK3 | 0.21177025 |
| 128 | MAP3K5 | 0.18935932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.84902797 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.79873709 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67218203 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43804693 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35093135 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.25457946 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.25043857 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24289924 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.19681888 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.17546564 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14387551 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.08434078 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08247854 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.05348452 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95002613 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.89188456 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85897627 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82276141 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.79593161 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.77542720 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71916652 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.71517487 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70198336 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.64218422 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63861081 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63642542 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.63032077 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61802064 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.55311858 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51401170 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.48590607 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44350583 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44172050 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43891457 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42506507 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.40237802 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37473120 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.37435756 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37287268 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36205436 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.35996503 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.33646157 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32649487 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27143034 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24829949 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.24613580 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08156713 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07067681 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96821019 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94323246 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92872511 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90697778 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88561197 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88471112 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.85070472 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80807326 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80398453 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78599484 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77095098 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76672574 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.75328023 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74273496 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70914664 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70591171 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70480584 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64740244 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60922548 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60171762 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59852409 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.59270941 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.57790998 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.56365271 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.55984024 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.53387339 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52453803 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52234418 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49271772 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48303693 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46767274 |
| 80 | Proteasome_Homo sapiens_hsa03050 | 0.45880766 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45047638 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.44975343 |
| 83 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44155374 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42643950 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42180118 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38374952 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37899770 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35893077 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35753254 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34988443 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34617502 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34600607 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34275323 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.33597750 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33466595 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32692109 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32029674 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.30939631 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30915405 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29533939 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29414429 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.28838675 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26479217 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25372372 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24212629 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23850526 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21967658 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21749251 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21465186 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20549995 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20338544 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20194506 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18829184 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16936170 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15851479 |

